Growth Factors · 2007 · 31 citations · 29 references
Life SciencesCell BiologyMolecular BiologyApoptosisCell SignalingSignal TransductionApoptosis ModulationGrowth Factor SignalingMitochondrial DysfunctionMitochondrial FunctionMitochondrial SignalingMitochondrial Stress ResponsesAntiapoptotic Protein RegulationAntiapoptotic Protein SignalingAnticancer ActivityInsulin ReceptorsMitochondrial Cell Death PathwaysMitochondrial Pathway Of ApoptosisReceptorsSurvivin Inhibition
Insulin-like growth factor II (IGF-II) plays a pivotal role in fetal and cancer development by signaling through the IGF-I and insulin receptors and activating the estrogen signaling cascade. We previously showed that precursor IGF-II (proIGF-II, the predominant form expressed in cancer) and not mature IGF-II (mIGF-II) blocks resveratrol (RSV) (a phytoalexin/anticancer agent)-induced cell death in MCF-7 cells. We hypothesize that proIGF-II regulates antiapoptotic proteins and/or the mitochondria to inhibit RSV actions and promote cell survival. This study examines the effect of mIGF-II and proIGF-II on survivin expression and mitochondrial polarization in response to RSV. RSV inhibits survivin expression and stimulates mitochondrial depolarization, caspase 7 activation and cell death. These effects were completely blocked by the addition of proIGF-II. RSV treatment had no effect on transfected MCF-7 cells constitutively expressing proIGF-II, while IGF-II siRNA transfection decreased survivin levels. Our results provide new insights for the potential use of proIGF-II as target for new anticancer therapies.
29
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
Meishiang Jang, Lining Cai, George Udeani et al. · Science · 1997 · 4.9K citations
Medicine, Oncology, Pharmacology +17
Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors α and β*
Jennifer L. Bowers, Valentyn V. Tyulmenkov, Sarah Jernigan et al. · Endocrinology · 2000 · 528 citations · Full text
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis
Takehiko Dohi, Elena Beltrami, Nathan R. Wall et al. · Journal of Clinical Investigation · 2004 · 354 citations · Full text